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ABSTRACT
The RDM1 gene encodes a RNA recognition motif
(RRM)-containing protein involved in the cellular
response to the anti-cancer drug cisplatin in verte-
brates. We previously reported a cDNA encoding the
full-length human RDM1 protein. Here, we describe
the identification of 11 human cDNAs encoding
RDM1 protein isoforms. This repertoire is generated
by alternative pre-mRNA splicing and differential
usage of two translational start sites, resulting in
proteins with long or short N-terminus and a great
diversity in the exonic composition of their
C-terminus. By using tagged proteins and fluores-
cent microscopy, we examined the subcellular
distribution of full-length RDM1 (renamed RDM1a),
and other RDM1 isoforms. We show that RDM1a
undergoes subcellular redistribution and nucleolar
accumulation in response to proteotoxic stress
and mild heat shock. In unstressed cells, the long
N-terminal isoforms displayed distinct subcellular
distribution patterns, ranging from a predominantly
cytoplasmic to almost exclusive nuclear localization,
suggesting functional differences among the RDM1
proteins. However, all isoforms underwent stress-
induced nucleolar accumulation. We identified
nuclear and nucleolar localization determinants as
well as domains conferring cytoplasmic retention to
the RDM1 proteins. Finally, RDM1 null chicken DT40
cells displayed an increased sensitivity to heat
shock, compared to wild-type (wt) cells, suggesting
a function for RDM1 in the heat-shock response.
INTRODUCTION
The RNA recognition motif (RRM) is a widespread
nucleic acid-binding domain of about 90 aa that displays
a conserved protein fold and, with the exception of
two small peptide motifs involved in RNA interaction
(RNP1 and RNP2), a great variability in sequence (1).
Although RRM domains are encountered primarily in
RNA-binding proteins, their targets are not restricted to
RNA. Thus, some RRMs have been shown to bind single-
stranded (ss) DNA (2–4) or double-stranded (ds) DNA
(5–8), or even to mediate protein–protein interactions
(9,10). RRM-containing proteins tend to have a modular
structure consisting of one or multiple copies of the RRM,
in association with other protein domains, such as the
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arginine (SR) protein family of splicing factors (11,12), or
the arginine-glycine-rich (RGG) domain found, for
instance, in nucleolin (13) and some heterogeneous
nuclear ribonucleoproteins (hnRNPs) (14). These auxil-
iary domains have been shown to act as protein–protein
interaction modules (15,16), participate in the interaction
with RNA (17) and/or contribute to the intracellular
localization of the protein (18–24). RRM-containing
proteins display a wide subcellular distribution that
reﬂects both the variety and multiplicity of their targets
and their essential participation in processes such as
transcriptional regulation, RNA splicing, editing and
processing, RNA export, sequestration, transport,
translation and stability, chromatin and telomere metab-
olism. In line with some of these activities, traﬃcking
between intracellular and/or intranuclear compartments
has been reported for several RRM-containing proteins,
illustrating a highly dynamic and regulated subcellular
distribution (25,26).
Recently, we identiﬁed a novel RRM-containing
protein in vertebrates. Disruption of the RDM1 gene
(for RAD52 Motif 1) encoding this protein in the chicken
B cell line DT40 resulted in an increased sensitivity to
the anti-cancer drug cisplatin (27). Using gel-shift assays
and electron microscopy, we showed that puriﬁed,
recombinant RDM1 binds RNA and ssDNA, as well as
dsDNA on which it assembles ﬁlament-like structures
(27,28). RDM1 was also able to recognize distortions
of the double helix caused by cisplatin-DNA adducts
in vitro. The primary sequence of RDM1 revealed a single,
N-terminal RRM but none of the auxiliary domains that
are known to be associated with this motif. However,
the RRM domain of RDM1 is followed by a short region,
named RD motif, which is conserved in the DNA
recombination and repair protein, RAD52 (27). In
RAD52, the region comprising this motif plays an
essential role in ssDNA binding (29). Biochemical analysis
of a chicken RDM1 variant mutated in its RD motif
revealed altered ssDNA-binding activity (28). Based on
these observations, we proposed a role for the RD motif
of RDM1 as a modulator of its RRM. To date,
the biological targets and function of RDM1 remain
unknown.
We previously reported the identiﬁcation of a human
cDNA encoding a 284-aa ORF corresponding to the
full-length RDM1 protein (27). In this report, we under-
took a reverse transcriptase (RT)-PCR analysis of RDM1
expression. We describe the identiﬁcation of eleven
cDNAs encoding RDM1 isoforms. This extensive reper-
toire is generated by alternative pre-mRNA splicing
and diﬀerential usage of two translational start sites,
resulting in proteins with long or short N-terminus and
a great diversity in the exonic composition of their
C-terminus. By using tagged proteins and ﬂuorescent
microscopy, we examined the subcellular distribution of
full-length RDM1, which was renamed RDM1a, and
some of long N-terminal isoforms. We found that
RDM1a undergoes subcellular redistribution and nucleo-
lar accumulation in response to proteotoxic stress
and mild heat shock. In the absence of stress, the long
N-terminal isoforms displayed distinct patterns of
subcellular distribution, ranging from a predominantly
cytoplasmic to an almost exclusive nuclear localization.
However, all isoforms underwent stress-induced
nucleolar accumulation. We identiﬁed nuclear and
nucleolar localization determinants as well as domains
conferring cytoplasmic retention to the RDM1 proteins,
thus providing a structural basis for the diversity of their
subcellular localizations. Finally, we report that RDM1
null chicken DT40 cells exhibit an increased sensitivity
to heat shock, compared to wild-type (wt) cells, suggesting
a novel function for RDM1 in the heat-shock response.
MATERIALS AND METHODS
Reagents and antibodies
Lactacystin and MG132 were from Calbiochem.
Cycloheximide, actinomycin D, a-amanitin and leptomy-
cin B were from Sigma. Oligonucleotides were purchased
from Invitrogen or Eurogentec. DRAQ5 was from
ALEXIS Biochemicals. The following antibodies were
used: mouse anti-Flag (M2) monoclonal antibody
(Stratagene), mouse anti-c-myc (clone 9E10) monoclonal
antibody (Sigma), mouse anti-PML (PG-M3) monoclonal
antibody (Santa Cruz), mouse anti-coilin (clone pd)
monoclonal antibody (Sigma), rabbit anti-nucleolin
(abcam, ab22758), tetramethyl rhodamine isothiocyanate
(TRITC)- and ﬂuoresceine isothiocyanate (FITC)-conju-
gated anti-rabbit and anti-mouse, aﬃnity-puriﬁed anti-
bodies (Jackson ImmunoResearch Laboratories).
Plasmid construction, site-directed mutagenesis and cloning
of RDM1isoforms
The primers used for this study are listed in
Supplementary Table 1. The human full-length RDM1a
ORF was PCR-ampliﬁed from a human testis cDNA
library using primers EV041 and EV042 incorporating
the ATG and stop codons, respectively, as well as
restriction sites to facilitate cloning. The PCR fragment
was digested with EcoRI and XhoI and cloned into the
EcoRI/XhoI sites of pBluescript II SK (Stratagene) to
generate pYG019. To construct pRDM1a-EGFP, the
RDM1a ORF was PCR-ampliﬁed from pYG019 using
primers EV061 and EV062, digested with XhoI and
BamHI, and cloned into the XhoI/BamHI sites of
pEGFP-N3 (BD Biosciences). To create pRDM1a-
mRFP, the BamHI/NotI fragment containing EGFP
from pRDM1a-EGFP was replaced with a BamHI/NotI
fragment containing monomeric red ﬂuorescent protein
(mRFP) from pcDNA3-mRFP (30), and in-frame fusion
was restored by site-directed deletion of the G present
between the BamHI site and the ATG of mRFP in
pcDNA3-mRFP. pEGFP-RDM1a was created by sub-
cloning a BamHI-ApaI fragment from pYG019 into
the BglII/ApaI sites of pEGFP-C1 (BD Biosciences).
To construct pFlag-RDM1a, the RDM1a fragment
ampliﬁed with EV041 and EV042 was digested with
NdeI, followed by end-blunting with the Klenow fragment
of Escherichia coli DNA polymerase I in the presence
of dNTPs, digestion with XhoI and cloning into the HpaI/
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the RDM1a ORF was ampliﬁed using primers EV061 and
EV062, followed by cloning into the XhoI/BamHI sites
of pcDNA3.1/myc-His(-)A (Invitrogen). To construct
pEGFP-RDM190–284, a RDM1a fragment was PCR-
ampliﬁed with primers EV280 and EV281, digested with
XhoI and BamHI and cloned into the XhoI/BamHI sites
of pEGFP-C1. pEGFP-RDM190–133 was created by
digesting pEGFP-RDM190–284 with HindIII and BamHI
to remove sequences corresponding to exons 4–7, followed
by end-blunting and self-ligation of the gel-puriﬁed
plasmid. pEGFP-RDM1a-E3, lacking all of exon3,
was constructed by PCR-based deletion, using primers
EV295 and EV281, as well as the complementary primers
EV293 and EV294 which overlap exons 2 and 4. The
resulting fragment was cloned into the XhoI/BamHI sites
of pEGFP-C1. pEGFP-RDM1133–284 was created by
cloning of a RDM1a fragment ampliﬁed with primers
EV304 and EV281 into the XhoI/BamHI sites of pEGFP-
C1. pEGFP-RDM11–92 was created by digesting pEGFP-
RDM1a-E3 with HindIII and BamHI to remove exons
4–7, followed by end-blunting and self-ligation of the gel-
puriﬁed plasmid. To create pRDRDM1-EGFP, the RD
motif of RDM1 was PCR-ampliﬁed using primers EV300
and EV301, followed by cloning into the XhoI/BamHI
sites of pEGFP-N3.
Site-directed mutagenesis of exon 3 in pEGFP-
RDM190–133 was carried out with the mutagenic primer
pairs EV296-EV297 (Y120YF-AAA) or EV298-EV299
(R98HK-AAA) using the QuickChange Site-Directed
Mutagenesis kit from Stratagene. The isoforms of
RDM1 containing long or short N-terminal sequences
were ampliﬁed by RT-PCR on total RNA from HEK293T
cells using primers EV061 and EV281, or EV254 and
EV042, respectively. Following gel-puriﬁcation and
digestion with XhoI and BamHI, the bands were cloned
into the XhoI/BamHI sites of pEGFP-C1. All constructs
were conﬁrmed by sequencing. The nucleotide sequences
of the RDM1 isoforms have been submitted to
the GenBank
TM/DDBJ/EBI data bank with accession
numbers EF488473-EF488482.
Fibrillarin-RFPCherry was generated by replacing
the GFP in Fibrillarin-GFP (31) by a RFPCherry KpnI/
BamHI fragment generated by PCR from RFPCherry
in pRSETB vector (kind gift from Dr R.Y. Tsien,
University of California, San Diego, CA).
Human cell culture andtransfection
HEK293, HEK293T, HeLa and MCF7 cells were main-
tained in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
supplemented with 10% foetal bovine serum (FBS), 1mM
sodium pyruvate, 2mM L-glutamine, penicillin and strep-
tomycin (Gibco-BRL). Cells were maintained in a 5% CO2
atmosphere at 378C. For some experiments, cells were
grown in CO2-independent medium (Invitrogen) supple-
mented with 10% FBS and 4mM L-glutamine. Cells were
transiently transfected using Superfect (Qiagen), or
FuGENE 6 (Roche). Stable pools of HEK293 clones
expressing RDM1a-EGFP and EGFP-RDM1a were
obtained following transfection with pEGFP-RDM1a
and pEGFP-RDM1a, respectively, using Eﬀectene
(Qiagen), and selection with G418 (1mg/ml)(InvivoGen).
Isolated clones were further puriﬁed by serial dilutions.
For localization experiments with Fibrillarin-
RFPCherry, HeLa cells were transfected with both
pRDM1a-EGFP and Fibrillarin-RFPCherry by electro-
poration (electroporator ECM 830; BTX), using 7mg
plasmid DNA and 15mg sheared salmon sperm carrier
DNA in a 2mm gap cuvette containing 10
4 cells in a ﬁnal
volume of 200ml, at 200V, 1ms pulse, four pulses and 0.5s
intervals. After electroporation, the cells were grown
overnight on 22mm square coverslips each deposited on
the bottom of a six-well plate, followed by treatment with
MG132 and processing for confocal microscopy as
described further.
Proteotoxic stress, heatshock andinhibition oftranscription
HeLa or HEK293T cells were treated with lactacystin
(10mM) or MG132 (10 or 25mM) for the indicated
time. Heat stress was applied to cells grown in CO2-
independent medium by incubation at 438C for 30min in
a water bath as described by Chatterjee and Fisher (32).
For speciﬁc transcriptional inhibition of RNA pol I, or
for inhibition of both RNA pol I and pol II, cells were
treated for 2h with 50ng/ml (33) or 5mg/ml (34)
actinomycin D, respectively. For speciﬁc inhibition of
RNA pol II, 50mg/ml a-amanitin were added to the cells
for 5h (35).
ChickenDT40 cell cultureand survival assays
DT40 cell culture was done as previously described (36).
The analysis of cell survival following heat-shock treat-
ment was carried out using colony formation assays,
by plating serially diluted, heat-stressed cells in complete
medium containing 1.4% methylcellulose followed by
incubation at 39.58C. Colonies were counted at  10 days
after plating. Cell survival following exposure to MG132
was determined by FACS analysis using a FACSCalibur
(Becton Dickinson). Cells were stained with propidium
iodide (PI) without ﬁxation, and dead cells were deﬁned
as PI-positive cells.
Immunofluorescence andmicroscopy
Cells were seeded in chambered cover glasses (Lab-Tek)
16–20h after transfection, and used in experiments  48h
following transfection. For direct immunoﬂuorescence
analysis, cells were ﬁxed with 2% paraformaldehyde
in PBS for 15min at room temperature and washed
three times with PBS, and the cell nuclei were counter-
stained with DRAQ5 (1/5000 in PBS) for 5min. For
indirect immunoﬂuorescence, cells were ﬁxed with 2%
paraformaldehyde in PBS for 15min, permeabilized
for 5min in 0.2% Triton X-100 in PBS, and then blocked
in PBS containing 0.1% FBS, 1% BSA and 0.2% Triton
X-100 for 1h at room temperature or overnight at 48C.
Cells were then incubated with the indicated primary
antibodies (diluted in PBS containing 0.1% FBS, 1% BSA
and 0.2% Triton X-100) for 1h 45min at room
temperature, rinsed three times with 0.05% Tween 20 in
PBS and incubated with TRITC- or FITC-conjugated
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Cells were then rinsed twice with 0.05% Tween 20 in PBS,
followed by counterstaining of the cell nuclei with
DRAQ5 as described above. Primary antibodies were
used at the following dilutions: 1:2000 (anti-nucleolin),
1:1000 (anti-Flag), 1:500 (anti-c-myc), 1:125 (anti-coilin),
1:100 (anti-PML). Secondary antibodies were used at a
1:200 (anti-mouse) or 1:1000 (anti-rabbit) dilution.
Confocal microscopy was carried out using a Zeiss
LSM510 laser scanning microscope.
For the visualization of HeLa cells expressing
pRDM1a-GFP and Fibrillarin-RFPCherry, control or
MG132-treated cells were ﬁxed in 3.5% paraformaldehyde
at room temperature for 15min. Cells were then washed
with PBS three times for 10min before ﬁnal mounting in
Vectashield mounting medium containing DAPI (Vector
Laboratories, Inc.). Cells were observed using ZeissMeta
confocal microscope with a 100  1.3N.A. oil immersion
objective lens.
For the visualization of nucleolar RNA, control
or MG132-treated HeLa cells were incubated with the
RNA-selective ﬂuorescent probe F22 (10mM) (37) for
20min at 378C. Cells were then ﬁxed in 3.5% parafor-
maldehyde and prepared for microscopy as described
above. RNA staining of HEK293T cells was carried out
by incubating paraformaldehyde-ﬁxed cells with F22
(5mM) for 20min at room temperature.
RNA extraction and RT-PCR analysis
Total RNA was extracted using the TRIzol reagent
according to the manufacturer’s instructions (Invitrogen),
and reverse transcribed with SuperScript II Reverse
Transcriptase (Invitrogen). RDM1 cDNAs were ampliﬁed
with the indicated primers. For semiquantitative RT-PCR
analysis of RDM1 expression, its cDNAs were co-ampli-
ﬁed with b-actin (primers F-actin and R-actin). The PCR
reaction mixture was denatured for 5min at 948C, cycled
35 times (948C, 30s; 618C, 30s; 728C, 1min), followed by a
7min extension at 728C.
RESULTS
Identification of isoformsof human RDM1
We have previously reported the identiﬁcation, from testis
and brain cDNA libraries, of a human cDNA encoding a
284-aa ORF corresponding to the full-length RDM1
protein (27). This ORF is encoded by seven exons varying
in size between 86 and 360nt and interrupted by introns
between 376 and 4438nt long (see Supplementary Tables 2
and 3 for the coordinates of the RDM1 ORF on
chromosome 17 and its exon/intron organization, respec-
tively). Preliminary RT-PCR analyses using primers
designed to amplify the complete RDM1 ORF from a
variety of tissues and cell lines suggested the expression of
isoforms arising from alternative splicing (data not shown,
see also below). Limited evidence for alternative splicing
of RDM1 pre-mRNA was also reported in the AceView
annotations of the National Center for Biotechnology
Information (NCBI) human genome database (http://
www.ncbi.nih.gov/IEB/Research/Acembly/index.html).
In addition, the database suggested the existence of an
alternative translation initiation codon located within
intron 1 (position 495 on sequence accession number
NC_000017.9) (Figure 1A). To learn more about the
various forms of RDM1, we carried out a RT-PCR
analysis on total RNA from HEK293T cells, using primer
pairs designed to amplify isoforms containing the ﬁrst
ATG (hereafter referred to as long N-terminal forms). Gel
analysis revealed a major band corresponding to the
Figure 1. Structure of the human RDM1 gene and the RDM1 protein
isoforms. (A). Schema of the RDM1 gene structure. Exons are
numbered and arrows indicate the translation initiation codons used
to produce proteins with long (RDM1) or short (N-RDM1)
N-terminal sequences. Greek symbols designate the splice variants
detected in this study. Introns are not drawn to scale, and only the
coding regions of exon 1 and 7 are shown. Whether the short and long
N-terminal forms arise by use of two alternative transcription initiation
sites within the RDM1 gene is presently unknown. (B) RT-PCR
analysis of the expression of the long (left panel) and short (right panel)
N-terminal RDM1 isoforms in HEK293T cells. RT-PCR were carried
out as described under ‘Materials and Methods’ section and analysed
by agarose gel electrophoresis. (C). Structure of the RDM1 protein
isoforms theoretically encoded by the RDM1 cDNAs characterized
in this study. Full-length RDM1 protein (284 aa) was renamed
RDM1a. Numbers refer to the ﬁrst amino acid of each exon. See
text for details.
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lower intensity (Figure 1B, left panel). Similarly, reactions
carried out with primers designed to amplify short N-
terminal forms (containing the second ATG) revealed four
bands (Figure 1B, right panel). Identical proﬁles were
obtained with cDNA prepared from HeLa and MCF7
cells (data not shown, see also below). After sequencing,
we established that the various bands obtained in each
reaction corresponded to alternatively spliced variants. In
total, nine RDM1 cDNAs were characterized in this
analysis. The structure of the RDM1 proteins encoded by
these cDNAs is illustrated in Figure 1C. Full-length
RDM1 was renamed RDM1a. We used the preﬁx N- to
designate isoforms translated from the second ATG,
which lack exon 1 and contain an additional 9aa in
front of exon 2. Additional nomenclature was devised
to reﬂect the presence of exons 2–7 (RDM1a and
N-RDM1a), or the exclusion of exon 4 (RDM1b and
N-RDM1b), exon 5 (RDM1g and N-RDM1g),
exons 2+4 (RDM1d) and exons 4+5 (RDM1e and
N-RDM1e). Skipping of exon 4 in the b and d isoforms
results in a frame shift and premature termination within
exon 5. Premature termination also occurs within exon 6
in the e isoforms. In contrast, no frame shift accompanies
the loss of exon 5 in the g isoforms (Figure 1B). With the
exception of RDM1d, which does not contain exon 2, all
isoforms contain exons 2 and 3. The RT-PCR data of
Figure 1B suggest that RDM1a and N-RDM1b are the
most abundant forms produced from the ﬁrst and second
translation initiation codon, respectively. Finally, two
additional isoforms (named RDM1  and N-RDM1 ,
arising from the exclusion of exons 4–6) were identiﬁed
in cells exposed to a mild heat shock (see below and
Figure 1). Thus, alternative pre-mRNA splicing and
diﬀerential usage of two translational start sites generate
an extensive repertoire of RDM1 isoforms.
Cytoplasmic and nucleardistribution of RDM1a
As a step to elucidating the function of the RDM1
proteins, we ﬁrst generated RDM1a fusion proteins
containing N-terminal [enhanced green ﬂuorescent protein
(EGFP), Flag] or C-terminal [EGFP, mRFP, c-myc] tags
and analysed their subcellular distribution in the human
cell lines HEK293T and HeLa by transient transfection
and confocal ﬂuorescence microscopy. Images of repre-
sentative cells are shown in Figure 2 and Supplementary
Figure S1. In both cell types, and regardless of the nature
and the location of the tag on RDM1a, the fusion proteins
were found predominantly in the cytoplasm and, to a
minor extent, in the nucleus. The fusion proteins were
largely excluded from the nucleolus, which was identiﬁed
by phase contrast illumination and chromatin staining
(Figure 2A, B), and also by indirect immunoﬂuorescence,
using an antibody against the resident nucleolar protein
nucleolin (Figure 2C). This pattern of distribution was
also observed in HuH7 cells, as well as in living HEK293
cells and in cells stably expressing the EGFP-protein
fusions (data not shown and see below). Treatment of the
cells with leptomycin B (20ng/ml), a known inhibitor of
the nuclear exporter protein CRM1 (38,39), did not lead
to the accumulation of the fusion proteins in the nucleus
(data not shown), suggesting that RDM1a did not
undergo CRM1-mediated nuclear-cytoplasmic shuttling.
Proteasome inhibition induces the subcellular redistribution
ofRDM1aand its nucleolar accumulation
We then tested whether various forms of cellular stress
had any eﬀect on RDM1a subcellular localization.
Treatment with lactacystin or MG132, two speciﬁc
proteasome inhibitors (40–42), resulted in a dramatic
redistribution of the fusion proteins. As illustrated for
EGFP-RDM1a in Figure 3A and B, the major eﬀect of
these drugs was the accumulation of the fusion proteins in
the nucleolus. When the confocal settings were optimized
for the visualization of the GFP signal in the nucleolus
(Figure 3B, second image), or in cells expressing less
protein fusions (Figure 3C), the fusion protein could be
seen to form circular or more entangled structures that
sometimes overlapped with peri-nucleolar chromatin
(Figure 3C) or resided within the nucleolus (Figure 3B;
Figure 2. Subcellular localization of RDM1a. (A–B) Confocal micro-
scopic images of HeLa cells expressing EGFP-RDM1a
(A) and HEK293T cells expressing RDM1a-EGFP (B). Cells were
ﬁxed and counterstained with DRAQ5 (blue) prior to visualization.
Green represents EGFP-tagged RDM1a.( C) HEK293T cells
transfected with pFlag-RDM1a were double stained for nucleolin
(red) and the Flag epitope (green). Cell transfection and immunoﬂuor-
escence analysis were carried out as described under ‘Materials and
methods’ section.
Nucleic Acids Research, 2007, Vol. 35, No. 19 6575Figure 3. Subcellular redistribution and nucleolar accumulation of RDM1a in response to proteotoxic treatment. (A–B) HEK293T cells transiently
expressing EGFP-RDM1a were treated with 10mM MG132 (A) or lactacystin (B) for 4h, followed by ﬁxation, counterstaining with DRAQ5 (blue)
and confocal microscopic analysis. The second image of (B) is identical to the ﬁrst, except that the confocal settings have been optimized for the
6576 Nucleic Acids Research, 2007, Vol. 35, No. 19see also Figure 3E–G). In addition to these structures,
accumulation of the green ﬂuorescent protein (GFP)
signal as nucleolar foci was also observed in some
cells (Figure 3D). Identical results were obtained with
cells expressing Flag-tagged RDM1a (Figure 3E).
Quantiﬁcation of the subcellular distribution patterns
of EGFP-RDM1a in HeLa cells treated with MG132
(10mM) indicated that after 2 and 8h of treatment,
nucleolar accumulation of the fusion protein as circular/
entangled structures could be observed in about 40%
(138 cells examined) and 74% (73 cells examined) of the
cells, respectively. At these time points, the percentages of
cells displaying general accumulation of the GFP signal in
the nucleus without detectable nucleolar accumulation
were 53 and 16%, respectively, and <10% of the cells
showed nucleolar foci.
To learn more about the localization of RDM1a within
the nucleolus, cells expressing RDM1a-EGFP were
treated with lactacystin or MG132 and stained with an
antibody to nucleolin, a very abundant nucleolar protein
involved in ribosomal DNA (rDNA) transcription, rRNA
processing and ribosome assembly (43). As illustrated
in Figure 3F and G, although RDM1a and nucleolin were
very closely associated, little or no overlap was observed
between the two proteins. Likewise, RDM1a did not
co-localize with ﬁbrillarin, a factor involved in pre-rRNA
processing (44,45) (Figure 3H). However, RNA staining
with the RNA-selective dye F22 (37) revealed an extensive
overlap between RDM1a and nucleolar RNA, even
though large regions of the nucleolar RNA did not
contain RDM1a (Figure 3I). Inhibition of the proteasome
has been shown to induce the disruption of nucleolar
architecture and alter the distribution of nucleolar
proteins, including nucleolin and ﬁbrillarin, as well as
rRNA and rRNA precursors (46). Thus, partial segrega-
tion of rRNA precursors and their processing factors
was observed in response to proteasomal inhibition,
and factors involved in early and late preRNA processing,
which overlapped extensively in the absence of stress,
underwent spatial separation after MG132 treatment (46).
Our observations therefore suggest that part of the rRNAs
redistributed in response to proteasomal inhibition
might become targets for RDM1a accumulating in the
nucleolus.
In addition to promoting its nucleolar accumulation,
proteotoxic treatment also aﬀected the overall distribution
of RDM1a in the nucleoplasm. In particular, dot-like
or more irregular subnuclear structures containing
RDM1a were found to accumulate in many cells treated
with MG132 or lactacystin (see for instance, Figure 3A,
B and D). We considered the possibility that these
structures corresponded to speciﬁc nuclear bodies. When
stressed cells were stained with antibodies directed against
the promyelocytic leukemia (PML) protein, a component
of PML bodies (47), extensive juxtaposition or colocaliza-
tion of some RDM1a-containing structures with PML
was observed (Figure 4A), suggesting the association of
RDM1a with PML bodies. These nuclear bodies have
been implicated in several processes such as sensing of
cellular stress (48), transcriptional regulation (49,50) and
chromatin remodeling (51). Several indications also
suggest that they function as storage sites, to regulate
protein activity within the nucleus (47). In many cells,
PML-positive foci also accumulated in the nucleoli of cells
treated with proteasomal inhibitors (Figure 4B), consis-
tent with published studies showing that a fraction
of PML protein dissociated from the PML bodies
to relocate to the nucleolus in response to MG132
treatment (52). However, we found no correlation between
the presence of PML in the nucleolus and that of RDM1a
(data not show; see also Figure 4A, where no PML protein
is found in the nucleoli colonized by RDM1a).
Similar observations were made with cells treated with
lactacystin (data not shown).
Some RDM1a foci were also found to colocalize with,
or be adjacent to Cajal nuclear bodies (CBs), identiﬁed by
the marker protein p80 coilin (Figure 4C). CBs play a role
in the transport and maturation of small nuclear
ribonucleoproteins (snRNPs) involved in pre-mRNA
processing, as well as small nucleolar RNPs (snoRNPs)
involved in rRNA modiﬁcation and processing; they have
also been implicated in the cell response to stress (53). In
addition, whereas CBs do not colocalize with PML bodies,
they are often found in close proximity, suggesting the
exchange of components (47,53). The fact that RDM1a
can be found in association with both types of nuclear
bodies may therefore suggest some concerted action of
PML bodies and CBs during proteotoxic stress. Under
normal conditions, cells displaying nuclear RDM1a foci
were infrequent. However, colocalization with PML
bodies or CBs could sometimes be observed in foci-
positive cells (Figure 4D and E). Taken together, these
observations suggest that RDM1a interacts with PML
bodies and CBs under normal conditions, and that this
association greatly increases in response to proteotoxic
stress. Whether the recruitment of RDM1a to PML and
CBs serves as a sequestration mechanism to regulate its
activity, or reﬂects a biochemical function within these
bodies, is currently unknown.
analysis of the GFP signal within the nucleolus. (C) HEK293 cells stably expressing RDM1a-EGFP were treated with 10mM lactacystin for 8h and
living cells were analysed following counterstaining with DRAQ5. (D) HEK293T cell displaying the accumulation of the EGFP-RDM1a protein as
nucleolar foci in response to treatment with MG132 (10mM, 4h). (E) HeLa cells expressing Flag-RDM1a were treated with 10mM MG132 for 4h,
followed by ﬁxation and staining of the Flag epitope (red). Nucleolar foci and entangled structures can be seen in the left and right cells shown on
this image, respectively. (F–H) Lack of colocalization of stress-induced, nucleolar RDM1a with nucleolin and ﬁbrillarin. (F) HEK293T cells
expressing RDM1a-EGFP were treated with 10mM lactacystin for 8h, followed by ﬁxation and staining for nucleolin. Nuclei were counterstained
with DRAQ5 (blue). (G) HEK293 cells stably expressing RDM1a-EGFP were treated with 25mM MG132 for 8h and analysed as described for (F).
(H) HeLa cells expressing RDM1a-EGFP and Fibrillarin-RFPCherry were treated with 10mM MG132 for 8h followed by ﬁxation, counterstaining
with DAPI (blue) and visualization. Signals from EGFP (green) and nucleolin or ﬁbrillarin (red) were merged, revealing distinct distribution patterns.
(I) Colocalization of RDM1a with nucleolar RNA in MG132-treated cells. HeLa cells expressing RDM1a-EGFP were treated with MG132 (10mM
MG132, 8h) and the RNA was visualized with the cell-permeant, RNA-speciﬁc dye F22, followed by processing as for (H). In the merged image,
RDM1a-EGFP (green) and RNA (red) coincide extensively (yellow) within the nucleoli.
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Inhibition of proteasome-mediated protein degradation
leads to the accumulation of proteins normally targeted
for degradation as part of the execution of certain cellular
programmes or because they are aggregated, misfolded or
damaged (41). Accumulation of denatured proteins can
also be triggered by conditions such as heat shock (54).
Therefore, we determined whether a heat-shock stress
altered RDM1a subcellular distribution in HEK293T
and HeLa cells. Following transfection with plasmids
expressing the RDM1a protein tagged with EGFP, the
cells were subjected to a mild heat-shock treatment (438C,
30min) before ﬁxation and analysis. As illustrated
representatively for HEK293T cells in Supplementary
Figure S2A, the fusion protein accumulated in the
nucleolus in response to heat shock, forming circular
and more entangled structures. This accumulation,
which aﬀected essentially all cells, was reversible, as
more than 90% of the cells displayed normal subcellular
distribution of the fusion proteins after a recovery period
of 2h at 378C (data not shown). Furthermore, incubation
of the cells with cycloheximide (20mg/ml) for 1h prior to
heat shock did not inhibit the nucleolar accumulation
of RDM1a (Supplementary Figure S2B), indicating that
the heat-shock induced relocalization of RDM1a did not
depend on protein neo-synthesis.
Subcellular distribution of RDM1aduring
transcriptional arrest
Transcriptional inhibition represents a form of stress that
greatly aﬀects the architecture of the nucleolus.
Transcriptional arrest mediated by inhibition of RNA
polymerase I and/or II elicits nucleolar segregation and
the formation of nucleolar caps consisting of nucleolar
components originating from the original nucleolus,
Figure 4. Association of RDM1a-EGFP with PML and CBs. (A) Confocal micrographs of RDM1a-EGFP-transfected HEK293T cells following
treatment with MG132 (10mM, 4h) and staining of PML (red). The DNA was counterstained with DRAQ5 (blue). In addition to accumulating in
the nucleoli, RDM1a can be seen in numerous dot-like nuclear structures. Several of these dots (some of which are indicated by arrows) coincide
with or are in close proximity to PML bodies as illustrated in the merged image. Note that, in the cells depicted here, no PML protein is detected in
the nucleoli colonized by RDM1a.( B) Image of a MG132-treated cell (10mM, 8h) showing the partial accumulation of PML protein in nucleoli
colonized by RDM1a.( C) HEK293T cells transfected with RDM1a-EGFP were treated with MG132 (10mM, 2h), followed by staining of the CB
marker coilin (red). As illustrated in the merged image, some of the dot-like structures containing RDM1a (indicated by arrows) colocalize, or are in
close contact with CBs in MG132-treated cells. (D–E) Association of RDM1a with PML bodies (D) and CBs (E) in unstressed cells. The panels in
(E) represent two sections of the same cell showing dot-like structures containing RDM1a (indicated by arrows) that colocalize with CBs.
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study using concentrations of actinomycin D suﬃcient
to inhibit both RNA pol I and II (resulting in fully
segregated nucleoli), has shown that nucleolar segregation
is a dynamic process that also involves the redistribution
of nucleoplasmic proteins and RNAs (34). Thus,
in response to transcriptional arrest, the deﬁning regions
of the nucleolus [ﬁbrillar centres, dense ﬁbrillar compo-
nents and granular components (GC)] redistributed in
domains called nucleolar caps and central body (that was
originally the GC). Although some nucleolar proteins
(mainly from the GC) dispersed in the nucleoplasm after
transcriptional arrest, these domains retained many of
their original proteins and RNAs. In addition, proteins
and RNA components from many nuclear bodies
relocated to discrete nuclear caps, whereas numerous
nucleoplasmic proteins, including several RNA-binding
proteins, formed large nucleolar caps (34, and references
therein). Because it can occur under physiological states
and can be followed by nucleolar reassembly, Shav-Tal
et al. (34) have proposed that nucleolar segregation
evolved as a ﬂexible mechanism to redistribute speciﬁc
nuclear components in response to transcriptional arrest,
whilst keeping certain basic interactions, thus facilitating
eﬃcient reassembly upon transcriptional resumption.
To determine its possible involvement in nucleolar
capping caused by transcriptional arrest, we examined the
subcellular distribution of RDM1a in response to speciﬁc
inhibition of RNA pol I (50ng/ml actinomycin D, 2h)
(33), inhibition of both RNA pol I and pol II (5mg/ml
actinomycin D, 2h) (34) or speciﬁc inhibition of RNA pol
II (50mg/ml a-amanitin, 5h) (35). In all cases, RDM1a
remained predominantly cytoplasmic, whilst being also
present in the nucleus, as observed with untreated cells
(Supplementary Figure S3). This suggested that ongoing
transcription was not required for its nucleocytoplasmic
distribution. In the majority of cells, low levels of
actinomycin D, which caused p80 coilin to redistribute
at the nucleolar periphery, had little apparent eﬀect on
the subcellular localization of RDM1a (data not shown).
In a few cells, however, some RDM1a protein could be
seen at the rim of the nucleolus, where it partially
overlapped with p80 coilin, as well as in the centre of
the nucleolus (Supplementary Figure S3A). In contrast,
cells treated with high levels of actinomycin D, consis-
tently showed the relocalization of a fraction of RDM1a
in nucleolar rings or cap-like structures that were
surrounded by a dense chromatin ring from which the
protein was excluded, and some protein also colonized the
centre of the nucleolus (Supplementary Figure S3B). Little
or no overlap was observed between RDM1a and p80
coilin in these structures. Nucleolar relocalization of
RDM1a was much less apparent when a-amanitin was
used to inhibit RNA pol II speciﬁcally, although in
some instances a fraction of RDM1a could also be seen at
the nucleolar periphery (Supplementary Figure S3C).
Because RDM1 null cells display increased sensitivity
to cisplatin (27), and since cisplatin has been shown to
inhibit rRNA synthesis and cause nucleolar segregation
(58), we tested whether RDM1a relocated to nucleolar
caps in response to cisplatin. However, no redistribution
of RDM1a was seen following treatments with doses of
cisplatin at which nucleolar segregation is reported to
occur [10mg/ml, 8h (58)] (data not shown). Taken
together, our observations suggest that eﬃcient nucleolar
capping by RDM1a requires the extensive nucleolar
segregation that occurs upon inhibition of both RNA
pol I and pol II (34, and references therein).
Heat-shocksensitivityofRDM1-deficientchickenDT40cells
We next wanted to examine the importance of the RDM1
gene in the cellular response to proteotoxic stress and
heat shock. We have previously described the construction
of null cells lacking RDM1 by gene disruption in the
chicken B-lymphoid cell line DT40 (27). We ﬁrst
compared the survival of wt and RDM1
 /  cells following
exposure at various temperatures for diﬀerent periods.
DT40 cells grow at the maximal rate at the physiological
temperature of 39.58C, and their survival at high
temperatures depends on conserved as well as avian-
speciﬁc heat-shock transcription factors (59). No diﬀer-
ences in viability were observed at the moderately
high temperature of 428C (data not shown). However,
RDM1
 /  cells displayed a mild increase in sensitivity to a
heat shock carried out at 458C (Figure 5A). Finally,
compared to wt cells, RDM1
 /  cells were not hypersen-
sitive to MG132 (Figure 5B).
Transcripts encodingnovel isoformsof human RDM1
accumulate inresponse toheat shock
We next used semi-quantitative RT-PCR to examine the
mRNA expression patterns of the RDM1 isoforms
in HEK293T, HeLa and MCF7 cells subjected to a heat
shock (438C, 45min). As representatively illustrated for
HEK293T cells in Figure 6A, the expression pattern of
the long N-terminal forms was essentially unchanged
following heat shock, except for a slight increase in the
intensity of the band corresponding to RDM1e, and the
apparent accumulation of RDM1d. However, after
sequencing, we established that the observed accumula-
tion was due to the presence of a novel isoform with the
same size as RDM1d. This splice variant, which lacks
exons 4–6, was named RDM1  (see Figure 1). We
conﬁrmed the heat-shock inducibility of RDM1  expres-
sion using speciﬁc PCR primers (Figure 6B). Likewise, the
expression pattern of the short N-terminal forms revealed
that a novel form corresponding to N-RDM1  accu-
mulated in a heat–shock dependent manner, whereas the
other N-isoforms were downregulated in response
to heat shock (representatively illustrated for MCF7
cells in Figure 6C). Taken together, these data suggest
that the expression of the human RDM1 gene is
modulated by heat-shock stress.
Nuclear and nucleolar localization determinants in exon
3ofRDM1
Because RDM1a is present both in the cytoplasm and
nucleus and can also relocate to the nucleolus, we next
sought to identify the determinants of its subcellular
distribution. Since exon 3 is common to all the isoforms
reported here, we ﬁrst looked whether it contained speciﬁc
Nucleic Acids Research, 2007, Vol. 35, No. 19 6579intracellular localization signals by expressing a EGFP-
RDM190–133 fusion protein in HeLa cells. (A schematic of
all the constructs used in this study is shown in Figure 9F).
As illustrated in Figure 7A, the fusion protein displayed a
prominent signal in the nucleus, and in particular in the
nucleolus; only little GFP signal was detected in the
cytoplasm where a punctuate pattern was sometimes
observed. Exon 3 must therefore contain nuclear and
nucleolar localization domains. Classical nuclear localiza-
tion signals (NLS) consist of one (monopartite NLS) or
two (bipartite NLS) stretches of basic amino acids residues
(60). Likewise, stretches of basic residues (in single or
multiple copies) have been found in the nucleolar
localization signal (NoLS) of numerous proteins (25,61,
and references therein), whereas other proteins rely on
their nucleic acid-binding domains to associate with the
nucleolus (62). The 41-aa sequence of exon 3 contains a
stretch of basic residues at position 98–100 (RHK), as well
as the previously identiﬁed RD motif (aa 104–132), which
the evidence suggests is involved in modulating the DNA-
binding properties of RDM1 (28) (Figure 7D). The RD
motif contains several aromatic residues that might be
involved in nucleic acid interactions. In a preliminary
experiment, we found that the RD motif on its own was
unable to mediate the nucleolar recruitment of EGFP
(data not shown). As a step to further delineate the
nuclear/nucleolar targeting regions of RDM1, we there-
fore substituted AAA for either RHK at position 98–100,
or YYF at position 120–122 of exon 3, within the EGFP-
RDM190–133 fusion protein. The (120–122) YYF-AAA
mutation did not aﬀect the subcellular distribution of the
fusion protein, which was still essentially nuclear and
nucleolar (Figure 7B). However, compared to wt exon 3, a
brighter GFP signal was consistently observed in the
nucleolus of cells expressing the (120–122) YYF-AAA
variant, suggesting that the mutation aﬀected intranuclear
traﬃcking. In contrast, the (98–100, RHK-AAA) muta-
tion dramatically reduced the levels of GFP signal
observed in the nucleolus (Figure 7C), indicating that
this stretch of residues was a crucial component of the
NoLS in exon 3. In addition, the (98–100, RHK-AAA)
variant accumulated less predominantly in the nucleus,
and a more intense GFP signal was found instead in the
cytoplasm, suggesting that aa 98–100 also played a role in
the transport of exon 3 into the nucleus. Identical
observations were made with HEK293T cells (data not
shown).
The localization data obtained with EGFP-RDM190–284
suggests that exon 3 might be involved in the stress-
induced nucleolar accumulation of RDM1a. To test this
notion, we analysed the subcellular distribution of an
EGFP-RDM1a-E3 fusion lacking exon3, under normal
conditions or following a mild heat stress. In the absence
of any stress, we found that the fusion protein was
cytoplasmic and nuclear, but excluded from the nucleolus
(Figure 7E). However, it still accumulated in the nucleolus
in response to heat shock (Figure 7F). Nucleolar
accumulation of the EGFP-RDM1a-E3 fusion was
also observed after treatment with proteasome inhibitors
(data not shown, see also below). These experiments
suggest that other domains of RDM1a can mediate its
nucleolar targeting.
Subcellular distribution of theRRM domainof RDM1
RRM domains have been shown to mediate the intracel-
lular localization of numerous proteins. The RRM
identiﬁed by Pfam spans residues 17–92 of RDM1;
Figure 5. Heat-shock sensitivity of RDM1 null chicken DT40 cells.
(A) Wt and homozygous RDM1-deﬁcient (RDM1
 / ) cells grown at
39.58C were incubated at 458C for the indicated periods, and surviving
cells were counted by colony formation assays. (B) RDM1 null cells are
not hypersensitive to MG132. Wt and RDM1
 /  cells were treated with
the indicated concentrations of MG132 for 24h, followed by staining
with PI and FACS analysis. Survival is expressed as a percentage, using
untreated cells as the 100% value. Colony survival assays and FACS
analysis were carried out as described under ‘Materials and Methods’.
Experiments were done in triplicates, and the results are shown with
standard deviations.
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putative RNP2 signature (LLVWEL) (aa 17–22), and
terminates at the end of exon 2 (aa 33–92). We therefore
examined the subcellular distribution of an EGFP-
RDM11–92 fusion protein. Figure 8A (left panel) shows
that the fusion protein is localized primarily in the nucleus,
with little GFP signal in the cytoplasm. This indicates that,
like exon 3, the RRM of RDM1 can also mediate nuclear
localization of EGFP. Whereas the EGFP-RDM11–92
fusion is clearly also nucleolar, it is mainly in the
nucleoplasm, in contrast to what was observed with the
EGFP-exon3 fusion. However, nucleolar accumulation of
the EGFP-RDM11–92 fusion was observed in response to
heat shock (Figure 8A, right panel).
To further explore the possible redundancy played by
its RRM and exon 3 in the subcellular localization of
RDM1a, we next examined the distribution of deletion
constructs lacking exons 1–2 (EGFP-RDM190–284)o r
exons 1–3 (EGFP-RDM1133–284). In the absence of
stress, both fusion proteins showed a subcellular distribu-
tion reminiscent of RDM1a, being predominantly cyto-
plasmic and also nuclear but not nucleolar (Figure 8B
and C, left panels). Moreover, both displayed nucleolar
accumulation in response to heat shock (Figure 8B and C,
right panels) or proteasomal inhibition (Supplementary
Figure S4). Taken together, these observations suggest
that the C-terminal half of RDM1a (exons 4–7) contains
cytoplasmic retention domains as well as determinants
involved in its stress-induced nucleolar accumulation.
Because RDM1a colocalized extensively with nucleolar
RNA in cells treated with inhibitors of the proteasome,
and to explore the role of its proposed nucleic-acid
binding motifs in mediating this interaction, we next
studied the distribution of the EGFP-RDM190–284 and
EGFP-RDM1133–284 fusions relative to nucleolin and
RNA in HEK293T cells treated with MG132. In both
cases, little or no overlap was seen between the fusion
proteins and nucleolin. In addition, the GFP signal of the
fusion proteins still coincided extensively with nucleolar
RNA (Supplementary Figure S4A and B). Similar
observations were made with the EGFP-RDM1a-E3
construct (data not shown). These observations suggest
that RDM1a may be recruited to nucleolar RNA
indirectly, via interactions with protein partners.
Similarly, the loss of exons 1–3 did not prevent the
association of the fusion proteins with PML or p80 coilin
(data not shown), indicating that the ability of RDM1a to
interact with nucleic acids is not required for its
recruitment to PML and CBs.
Subcellular distribution ofother RDM1 isoforms
The isoforms reported in this study arise from alternative
splicing events involving only splice donor and acceptor
sequences that delineate the exons of the full-length
RDM1a protein (Figure 1A). Therefore, in addition to
providing insights into their localization and function, the
study of these isoforms should also be indicative of the
contribution of its various exons to the subcellular
location of RDM1a. Figure 9 illustrates the subcellular
distribution patterns of selected isoforms expressed as
EGFP-protein fusions and observed in the absence of
stress (left panels) or in response to heat shock (right
panels). In this report, we restricted our analysis to the
long N-terminal isoforms. We found that RDM1b, which
lacks exons 4–7, was primarily nuclear and nucleolar
(Figure 9A), consistent with the localization determinants
assigned to the RRM and exon 3. In addition, the
nucleolar distribution pattern of RDM1b was hetero-
geneous, some transfectants displaying more GFP signal
in the nucleolus than others (Figure 9A, upper and lower
panels). A predominantly nuclear and nucleolar distribu-
tion was also observed with the heat-shock inducible
Figure 6. Eﬀect of mild heat-shock stress on human RDM1 gene expression. (A) Semiquantitative analysis of the cDNA expression pattern of the
long N-terminal RDM1 isoforms in control and heat-shocked HEK293T cells. (B) Heat-shock inducible upregulation of RDM1 . Speciﬁc PCR
ampliﬁcation was carried out using the primer pair EV041 (containing the ATG) and EV305 (which overlaps the junction between exon 3 and 7) to
produce a diagnostic band of 422 n. (C) cDNA expression pattern of the short N-terminal RDM1 isoforms in control and heat-shocked MCF7 cells,
illustrating the downregulation of N-RDM1a,- b,- g, and -e, and the upregulation of N-RDM1  in response to heat shock. RNA isolation and
semiquantitative RT-PCR analyses were carried out as described under ‘Materials and Methods’. Primers EV041 and EV042 (long N-terminal
isoforms), EV254 and EV042 (short N-terminal isoforms) were used in the reactions, together with primers for b-actin as internal control (see
Supplementary Table 1). C, control; HS, heat shock; M, molecular weight markers. See text for details.
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which only lacks exon 5, was also located predominantly
in the nucleus; little GFP signal was observed in the
cytoplasm. (Figure 9C). However, RDM1g was still
essentially non-nucleolar. Taken together, these
observations suggest that the nuclear/nucleolar targeting
domains present in the N-terminal part of RDM1a (exons
1–3) must be controlled in part by a cytoplasmic retention
signal located in exon 5, as well as by other domains that
modulate intranuclear traﬃcking and nucleolar accumula-
tion of the RDM1 proteins. These notions were, however,
complicated by the analysis of the RDM1d isoform
(consisting solely of exons 1 and 3), which was found
evenly distributed in the cytoplasm and the nucleus despite
lacking exons 4–7 (Figure 9D). This pattern contrasted
with the almost exclusive nuclear localization of exon 3
(see Figure 7A), indicating that, in the absence of stress,
the nuclear/nucleolar targeting functions mediated by
exon 3 can be partially neutralized by sequences located in
exon 1. Finally, all the isoforms studied here displayed
nucleolar accumulation in response to heat shock (right
panels of Figure 9A–D) or proteotoxic treatment (data
not shown).
We next analysed the eﬀect of actinomycin D on the
subcellular distribution of RDM1b and RDM1g, which
are predominantly nuclear under normal conditions but
diﬀer by their degree of nucleolar occupancy. RDM1b
(which is present in the nucleolus in the absence of stress)
was still distributed throughout the nucleus in cells treated
with actinomycin D (5mg/ml, 2h), with the exception of
those regions that stained strongly for DNA. However, a
bright GFP signal was now concentrated in concave
nucleolar caps (Figure 9E, panel a). The type(s) of
nucleolar cap in which RDM1b resides following inhibi-
tion of transcription is currently unknown. RDM1g
which, like RDM1a, is essentially excluded from the
nucleolus in the absence of stress, did not strongly relocate
in nucleolar caps during transcriptional arrest. Instead, a
fraction of it assembled into nucleolar cap- and ring-like
structures encircled by a dense chromatin ring, reminiscent
Figure 7. Nuclearand nucleolarlocalization signalsin exon3of RDM1a.
(A–C) HeLa cells expressing either wt exon 3 (A), the (120–122)
YYF-AAA variant (B) or the (98–100) RHK-AAA variant (C)a s
EGFP-RDM190–133 fusion proteins were ﬁxed and observed by direct
ﬂuorescence, under a confocal microscope. (D) Amino-acid sequence
of human RDM1 exon 3, showing the position of the mutations carried
out as well as the RD motif (boxed). (E–F) Deletion of exon 3 does
not prevent the nucleolar accumulation of RDM1a in response to heat
stress. HeLa cells expressing EGFP-RDM1a-E3 were observed in the
absence of stress (E) or following mild heat-shock treatment (438C,
30min) (F). Green represents EGFP-tagged exon 3 or RDM1a-E3
and blue represents DRAQ5-stained nuclei. See text for details.
Figure 8. Subcellular localization of the RRM domain as well as
N-terminal truncation mutants of RDM1a. Confocal microscopic
visualization of control (left panel) or heat-shocked (right panel)
HeLa cells expressing EGFP-RDM11–92 (A), EGFP-RDM190–284 (B)o r
EGFP-RDM1133–284 (C). Cells were ﬁxed and counterstained with
DRAQ5 (blue) prior to visualization.
6582 Nucleic Acids Research, 2007, Vol. 35, No. 19Figure 9. Subcellular distribution of various long N-terminal RDM1 isoforms. (A–D) HeLa or HEK293T cells expressing the cloned cDNAs as
EGFP-RDM1 fusions were left untreated (left panels) or treated with a mild heat shock (right panels) prior to ﬁxation and direct ﬂuorescence
analysis. (A) RDM1b in HeLa cells. The upper and lower panels illustrate the diﬀerences in the levels of nucleolar GFP signal observed among
trasnfectants. (B) RDM1  in HEK293T cells. (C) RDM1g in HeLa cells. (D) RDM1d in HeLa cells. Green represents the EGFP-tagged proteins and
blue represents DRAQ5-stained nuclei. (E) Eﬀect of high levels of actinomycin D on the association of RDM1b and RDM1g proteins with nucleolar
caps. HEK293T cells transfected with EGFP-RDM1b (panel a) or EGFP-RDM1g (panel b) were treated with actinomycin D (5mg/ml) for 2h,
followed by ﬁxation, DNA counterstaining with DRAQ5 and confocal microscopy. Strong accumulation of RDM1b is seen in nucleolar caps,
whereas the distribution pattern of RDM1g is more reminiscent of that observed with RDM1a.( F) Schematic representation of the RDM1 isoforms
and deletion constructs examined in this study and summary of their subcellular distribution. The position of the RRM and RD motifs is indicated
above the structure of RDM1a.
Nucleic Acids Research, 2007, Vol. 35, No. 19 6583of those seen with RDM1a (Figure 9E, panel b). Because
RDM1b consists only of exons 1–3, our observations
suggest that the remaining C-terminal exons of RDM1a
and RDM1g play a role in retaining these isoforms in the
nucleoplasm, thereby preventing a strong association with
components of the nucleolar caps during transcriptional
arrest.
In summary, in the absence of stress, the long
N-terminal isoforms of RDM1 showed subcellular
distribution patterns ranging from predominantly cyto-
plasmic to almost exclusive nuclear localization, and their
levels of nucleolar occupancy displayed great diﬀerences
(Figure 9F). Nucleolar accumulation of these isoforms
was observed in response to proteotoxic stress or heat
shock, whereas they assembled nucleolar cap-like struc-
tures following transcriptional arrest.
DISCUSSION
In this report, we have revealed an extensive repertoire of
isoforms generated by processing of the human RDM1
gene. Using primers designed to amplify alternatively
spliced variants produced from two translation initiation
sites, we have uncovered 11 cDNAs that are expressed in a
variety of cell lines under normal growth conditions or in
response to heat shock. While this manuscript was in
preparation, an mRNA with a diﬀerent 30-untranslated
region, which encodes a novel RDM1 isoform containing
the ﬁrst ﬁve exons of RDM1a followed by a small, speciﬁc
C-terminal extension was deposited in the NCBI database
(accession number NM_001034836.1), adding to the
complexity of this repertoire. The diversity of the
RDM1 proteins lies in the presence or absence of
sequences encoded by exon 1 and exons 4–7. Indeed, it
is notable that, with the exception of RDM1d, all the
RDM1 isoforms described to date contain exons 2 and 3.
That the RDM1 proteins articulate around these two
exons argues for their functional importance, as discussed
below.
As a step to elucidating the function of the RDM1
proteins, we have examined the intracellular localization
of RDM1a and the other long N-terminal forms
(containing exon 1). Our analysis has revealed a great
diversity in the subcellular distribution patterns of these
proteins. Thus, some variants were predominantly cyto-
plasmic, whereas others were almost exclusively nuclear.
Likewise, great diﬀerences were seen in the nucleolar
localization of these proteins. We suggest that the
observed diﬀerences in subcellular distribution reﬂect
functional diﬀerences among the RDM1 isoforms.
Our work has identiﬁed important determinants of the
subcellular localization of the RDM1 proteins in the
absence of stress. Exon 3, retained in all RDM1 isoforms,
was found to contain nuclear and nucleolar targeting
domains. Although NoLS and NLS signals remain to be
delineated with precision within the 41-aa sequence of this
exon, our data indicate that nucleolar accumulation of
EGFP-tagged exon 3 was critically dependent upon the
integrity of a small stretch of basic residues (R98HK).
NoLS, consisting of stretches of basic residues present in
single or multiple copies, have been identiﬁed in several
nucleolar proteins and proposed to function by providing
a protein-interaction interface with proteins that associate
with the nucleolus (25,61, and references therein).
Whether a similar mechanism applies to exon 3 remains
to be determined. Substitution of AAA for R98HK also
decreased the overall levels of exon 3 in the nucleus,
suggesting that these residues might be part of a NLS as
well. Nuclear and nucleolar targeting domains were not
restricted to exon 3 as a construct consisting of exons
1+2 was found to mediate the nuclear/nucleolar
localization of EGFP, arguing for an important function
of the RRM in the nucleus. Interestingly, the RRM
domain localized less predominantly to the nucleolus than
exon 3. The notion that both the RRM and exon 3 of
RDM1 contribute functions in the nucleus raises the
possibility of interplay between these domains. Studies of
human La, a RRM-containing protein involved in the
maturation of precursor RNAs located in the nucleoplasm
or nucleolus, indicate that its intranuclear traﬃcking
results from interplay between a functional NoLS and an
RRM that is essential for its exit from the nucleolus (25).
That a similar interplay operates between the NoLS of
exon 3 and the RRM in some of the RDM1 proteins
might explain the observed heterogeneity in nucleolar
abundance of the RDM1b isoform. Finally, our analyses
so far have been limited to the long N-terminal isoforms.
However, future studies of the short N-terminal RDM1
isoforms will be important since these forms lack exon 1
and thus the proposed RNP2 signature of the RRM.
Others have shown that deletion of RNP2 in RRM1
or RRM2 of human La protein aﬀected subnuclear
localization (63). Whether the loss of exon 1 in the short
N-terminal RDM1 isoforms aﬀects the integrity and/or
nucleic acid-binding properties of their RRM, as well as
the determinants of its subcellular distribution, remains to
be elucidated.
In addition to nuclear/nucleolar targeting domains, we
have identiﬁed domains involved in the cytoplasmic
retention of the RDM1 proteins. Comparison of the
subcellular distribution patterns of RDM1a and RDM1g
indicates that one such domain is located in exon 5, as loss
of this exon converts a predominantly cytoplasmic protein
into a primarily nuclear one. Likewise, analysis of
RDM1d suggests that sequences within exon 1 play a
role in cytoplasmic retention by partially neutralizing the
nuclear/nucleolar targeting functions of exon 3 to promote
its cytoplasmic localization. References to cytoplasmic
retention sequences are well documented in the literature
(64–67). Based on these and other studies, several
hypotheses can be made regarding the role of the
cytoplasmic retention regions identiﬁed in RDM1a.
Firstly, they could mask potential nuclear localization
signals located elsewhere in the protein, and require post-
translational modiﬁcation or conformational changes for
these signals to be exposed in order to allow nuclear
shuttling. Secondly, the cytoplasmic retention regions
could shelter nuclear export signals. Although RDM1a
does not contain the classical leucine-rich nuclear
export sequence (NES) found in the proteins exported
by CRM1 (68), nor the M9- or KNS-types of NES
6584 Nucleic Acids Research, 2007, Vol. 35, No. 19identiﬁed in hnRNPs (69,70), it is possible that it harbors
a yet-unidentiﬁed NES. Finally, the cytoplasmic retention
domains identiﬁed in this study could mediate important
protein interactions or participate in substrate recognition
in the cytoplasm. Since RDM1a is predominantly
cytoplasmic, it is therefore possible that its major
partners/targets reside primarily in the cytoplasm. We
propose that its cytoplasmic retention domains allow
RDM1a to fulﬁl RNA-binding activities in the cytoplasm.
In support of this notion, preliminary analyses of
immunopuriﬁed RDM1a complexes have identiﬁed cyto-
plasmic as well as nuclear RNAs associated with RDM1a
(Van Dyck et al., unpublished data). The characterization
of these RNAs should illuminate the biological role of
RDM1a in RNA metabolism.
Some RDM1 isoforms localized to the nucleolus in
the absence of stress, arguing for a function within
this nuclear organelle. Moreover, RDM1a and the long
N-terminal isoforms accumulated in the nucleolus in
response to certain stresses. The nucleolus assembles
around the clusters of rDNA repeats and its primary
function is to host ribosome biogenesis, including rDNA
transcription, rRNA processing and pre-ribosome assem-
bly. In addition to the factors involved in these reactions,
the nucleolus also hosts hundreds of proteins from many
functional classes that associate with the nucleolus in a
dynamic manner (71). It is now well documented that the
nucleolus plays an important role in stress responses (72),
and a growing list of proteins have been shown to be
excluded from or accumulate in the nucleolus in response
to various forms of stress such as DNA damage (73),
inhibition of transcription (71), proteasome inhibition
(32,72) and heat shock (32). The evidence suggests that
stress-induced nucleolar sequestration or release of a
protein can serve as a mechanism to regulate protein
function (72). The nucleolus can also function as a
reservoir for unfolded proteins transported by molecular
chaperones in an attempt to prevent damage to other
nuclear compartments (74). It has also been proposed that
nucleolar accumulation induced by inhibition of the
proteasome reﬂects the stabilization of high-turnover
proteins normally targeted for degradation in the nucleo-
lus (61). To date, however, it has not been possible to
detect the 26S proteasome in nucleoli (46, and references
therein). In this study, nucleolar recruitment of the RDM1
isoforms was observed in response to three forms of stress
that signiﬁcantly alter the architecture of the nucleolus
and its functions in rRNA transcription and/or proces-
sing; proteasomal inhibition (46), heat shock (75) and
transcriptional arrest (34). The partial association of
RDM1a with nucleolar RNA in MG132-treated cell
suggests that the targets of RDM1a might include
rRNAs or precursor rRNAs. Such association, however,
did not require the proposed nucleic acid-binding domains
of RDM1, indicating that it is mediated at least in part
by protein–protein interactions. Similarly, the presence
of RDM1 isoforms in nucleolar caps following transcrip-
tional arrest may reﬂect the existence of newly exposed
RNA and/or protein partners.
In this study, we found that chicken DT40 RDM1
 / 
cells were more sensitive than wt cells to a heat shock
carried out at 458C. RDM1 was dispensable for cell
survival after exposure to MG132, suggesting functional
redundancy in the mechanisms that operate in response
to proteasome inhibition or that RDM1 is speciﬁcally
required during the heat-shock response. We have
previously reported that disruption of RDM1 in chicken
DT40 cells conferred increased sensitivity to cisplatin (27).
In vitro, chicken RDM1 protein interacted with ss- and
dsDNA as well as RNA, and also recognized cisplatin-
DNA lesions, leading us to propose several direct
or indirect mechanisms by which RDM1 could modulate
the cell response to cisplatin (27,28). Whether there is a
functional link between the cisplatin- and heat-shock
sensitive phenotypes of RDM1 null cells is currently
unknown. Because physical agents and various chemicals
that cause DNA damage can induce the expression of
heat-shock proteins (HSPs), and since certain HSPs have
been proposed to play a role in DNA repair and genomic
stability (76,77, and references therein), it is possible that
RDM1 impacts on DNA repair by modulating the
expression and/or activity of HSPs. However, studies
with Ehrlich ascites tumor cells have shown that cisplatin
does not elicit a general stress response, inducing instead
the expression of the small heat-shock protein Hsp25 via a
transcription-independent mechanism (78). Others have
shown that multidrug resistance can be induced by
mechanisms dependent upon heat-shock factors (79, and
references therein), and it is therefore also possible that the
cisplatin-sensitive phenotype of RDM1 null cells results
from dysfunction of these factors in the absence of RDM1.
Finally, our data suggest that RDM1 plays a role in
the cell response to extremely high temperatures in
chicken cells. Avians present relatively high physiological
temperatures compared with mammals, and functional
diﬀerences have been observed between the heat-shock
factors that mediate survival at high temperatures in
avians and mammals. For instance, the functions fulﬁlled
by human HSF1 are distributed in chicken cells between
HSF1 and an avian-speciﬁc factor called HSF3, which is
required for resistance to extremely high temperatures (59,
and references therein). Thus, it will be important
to determine whether and how the heat-shock sensitive
phenotype of the chicken RDM1 null cells relates to the
subcellular redistribution and nucleolar accumulation
of the human RDM1 proteins as well as the up-regulation
of some human RDM1 isoforms seen after mild heat
shock.
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